Acorah Software Products - Accounts Production 16.4.675 true true 31 December 2023 1 January 2023 false true No description of principal activity 1 January 2024 31 December 2024 31 December 2024 07856562 Mr Willis Lee iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 07856562 2023-12-31 07856562 2024-12-31 07856562 2024-01-01 2024-12-31 07856562 frs-bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 07856562 frs-bus:FilletedAccounts 2024-01-01 2024-12-31 07856562 frs-bus:Micro-entities 2024-01-01 2024-12-31 07856562 frs-bus:EntityHasNeverTraded 2024-01-01 2024-12-31 07856562 frs-bus:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 07856562 frs-bus:Director1 2024-01-01 2024-12-31 07856562 2022-12-31 07856562 2023-12-31 07856562 2023-01-01 2023-12-31
Registered number: 07856562
Emmaus Medical Europe Limited
Unaudited Dormant Financial Statements
For The Year Ended 31 December 2024
Balance Sheet
Registered number: 07856562
2024 2023
£ £
Current assets 1,000 1,000
NET CURRENT ASSETS 1,000 1,000
TOTAL ASSETS LESS CURRENT LIABILITIES 1,000 1,000
NET ASSETS 1,000 1,000
CAPITAL AND RESERVES 1,000 1,000

Notes

1. General Information
Emmaus Medical Europe Limited is a private company, limited by shares, incorporated in England & Wales, registered number 07856562 . The registered office is The Clock House, Station Approach, Marlow, Buckinghamshire, SL7 1NT.
2. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2023: NIL)
- -
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Willis Lee
Director
27 June 2025